simufilam
·Code: PTI-125
simufilam: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Filana Therapeutics Inc. (FLNA) | Phase 3 |
FDA Decisions
Approval(FLNA)
Frequently asked questions
Who is developing simufilam?
simufilam is being developed by Filana Therapeutics Inc..
What is simufilam's latest FDA decision?
The most recent tracked FDA decision for simufilam is Approval, dated March 11, 2025.
Get deeper analysis on simufilam
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis